Palliative treatment for malignant jaundice: endoscopic vs surgical approach
- PMID: 15206487
Palliative treatment for malignant jaundice: endoscopic vs surgical approach
Abstract
In this retrospective, comparative study a total of 107 patients, presenting with malignant inoperable strictures of common bile duct, due to a pancreatico-biliary malignancy, underwent palliative treatments. In a group, consisting of 82 patients (76.64%), endoscopic stenting procedures were performed; polyethylene stents or self-expanding metal stents were applied in 37 and 45 patients, respectively. The prerequisites for a successful endoscopic stenting were a) accuracy of diagnosis and b) exclusion of patients presenting with tumors potentially treatable by a curative resection. In the other group, consisting of 25 patients (23.36%), biliary-enteric bypass procedures were performed. Endoscopic treatment was successful in 97.5% of the cases (80/82); complication rate was 7.3% (6 patients on 82), and mortality rate was 3.6% (3 patients on 82). Median hospital stay was 13.4 and 7.3 days in patients treated with plastic stents and metallic stents, respectively. Bypass surgery was successful in 99% of the cases (24/25); complication rate was 24% (6 patients on 25), and mortality rate was 16% (4 patients on 25). Median hospital stay was 26 days. For the patients in whom a curative resection could not be performed, both the above mentioned methods resulted in a high rate of immediate technical and therapeutic success. However, the surgical approach showed a significantly higher rate in procedure-related mortality and morbidity; in addition, the hospital stay lasted longer in surgically treated patients. The patients who are definitely unsuitable for curative resection are better managed by positioning a stent. The use of metal stents should be preferred in those less serious patients who may supposedly survive longer.
Similar articles
-
Endo-laparoscopic approach in the management of obstructive jaundice and malignant gastric outflow obstruction.Hepatogastroenterology. 2005 Jan-Feb;52(61):128-34. Hepatogastroenterology. 2005. PMID: 15783012
-
Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas.Am J Gastroenterol. 2006 Apr;101(4):735-42. doi: 10.1111/j.1572-0241.2006.00559.x. Am J Gastroenterol. 2006. PMID: 16635221
-
Biliary stent or surgical bypass in unresectable pancreatic cancer with obstructive jaundice.Acta Chir Scand. 1990 May;156(5):391-6. Acta Chir Scand. 1990. PMID: 1693463
-
[Palliative surgical and endoscopic therapy of malignant bile duct occlusion].Chirurg. 1994 Oct;65(10):836-48. Chirurg. 1994. PMID: 7529670 Review. German.
-
[Non-resectable neoplasms of the biliary duct: palliative surgery vs non-surgical management].G Chir. 1996 Aug-Sep;17(8-9):408-12. G Chir. 1996. PMID: 9004835 Review. Italian.
Cited by
-
Early surgical bypass versus endoscopic stent placement in pancreatic cancer.HPB (Oxford). 2016 Aug;18(8):671-7. doi: 10.1016/j.hpb.2016.05.008. Epub 2016 Jun 11. HPB (Oxford). 2016. PMID: 27485061 Free PMC article.
-
Surgical bypass vs. endoscopic stenting for pancreatic ductal adenocarcinoma.HPB (Oxford). 2009 Mar;11(2):118-24. doi: 10.1111/j.1477-2574.2008.00015.x. HPB (Oxford). 2009. PMID: 19590634 Free PMC article.
-
Nitinol biliary stent versus surgery for palliation of distal malignant biliary obstruction.Surg Endosc. 2010 Sep;24(9):2092-8. doi: 10.1007/s00464-010-0903-7. Epub 2010 Feb 21. Surg Endosc. 2010. PMID: 20174944
-
Palliative surgical bypass for pancreatic and peri-ampullary cancers.J Gastrointest Cancer. 2007;38(2-4):102-7. doi: 10.1007/s12029-008-9020-4. J Gastrointest Cancer. 2007. PMID: 18810668
MeSH terms
LinkOut - more resources
Medical